KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 78 filers reported holding KEZAR LIFE SCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $345,638 | -77.6% | 290,452 | -53.9% | 0.00% | – |
Q2 2023 | $1,543,054 | -54.1% | 629,818 | -41.3% | 0.00% | -100.0% |
Q1 2023 | $3,360,111 | +281.7% | 1,073,518 | +758.6% | 0.00% | – |
Q4 2022 | $880,218 | -43.8% | 125,031 | -31.3% | 0.00% | – |
Q3 2022 | $1,566,000 | -55.5% | 181,951 | -57.3% | 0.00% | – |
Q2 2022 | $3,523,000 | -38.4% | 425,998 | +23.9% | 0.00% | -100.0% |
Q1 2022 | $5,716,000 | +177.5% | 343,893 | +179.1% | 0.00% | – |
Q4 2021 | $2,060,000 | +478.7% | 123,199 | +198.8% | 0.00% | – |
Q3 2021 | $356,000 | +122.5% | 41,229 | +40.1% | 0.00% | – |
Q2 2021 | $160,000 | -14.9% | 29,425 | -6.6% | 0.00% | – |
Q1 2021 | $188,000 | +50.4% | 31,504 | +30.8% | 0.00% | – |
Q4 2020 | $125,000 | +6.8% | 24,093 | -1.0% | 0.00% | – |
Q3 2020 | $117,000 | +28.6% | 24,348 | +39.1% | 0.00% | – |
Q2 2020 | $91,000 | -97.7% | 17,504 | -98.1% | 0.00% | -100.0% |
Q1 2020 | $4,028,000 | +1461.2% | 924,034 | +1337.6% | 0.00% | – |
Q4 2019 | $258,000 | +18.3% | 64,274 | -3.3% | 0.00% | – |
Q3 2019 | $218,000 | +1.4% | 66,466 | +138.5% | 0.00% | – |
Q2 2019 | $215,000 | -72.0% | 27,863 | -35.6% | 0.00% | – |
Q1 2019 | $768,000 | – | 43,245 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |